Ashton Thomas Private Wealth’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $347K | Buy |
16,011
+2,997
| +23% | +$65K | 0.01% | 647 |
|
|
2025
Q1 | $316K | Buy |
13,014
+899
| +7% | +$21.8K | 0.01% | 635 |
|
|
2024
Q4 | $253K | Buy |
12,115
+276
| +2% | +$5.76K | 0.01% | 674 |
|
|
2024
Q3 | $235K | Buy |
11,839
+84
| +0.7% | +$1.67K | 0.01% | 556 |
|
|
2024
Q2 | $182K | Buy |
11,755
+342
| +3% | +$5.3K | 0.01% | 583 |
|
|
2024
Q1 | $182K | Buy |
11,413
+1,014
| +10% | +$16.2K | 0.01% | 577 |
|
|
2023
Q4 | $175K | Sell |
10,399
-190
| -2% | -$3.19K | 0.01% | 562 |
|
|
2023
Q3 | $124K | Buy |
10,589
+190
| +2% | +$2.22K | 0.01% | 550 |
|
|
2023
Q2 | $140K | Buy |
+10,399
| New | +$140K | 0.01% | 558 |
|